An evaluation of mechanically induced neurogenic flare by infrared thermography in fibromyalgia

Journal of Musculoskeletal Pain

Volumn 4, Issue 3, 1996, Pages 3-20

  Pik Yuk, Peggy ^a,d   Scudds, Hau Roger A ^b   Harth, Manfred ^c  

^a University of Western Ontario ^*  (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d WICHITA STATE UNIVERSITY   (United States)

Author keywords

Fibromyalgia; Ncurogcnic flare; Nociceptive; Sympathetic activity

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFRARED RADIATION; MALE; NEUROGRAPHY; PAIN ASSESSMENT; SKIN TEMPERATURE; SYMPATHETIC TONE; TEMPERATURE MEASUREMENT; THERMOGRAPHY;

EID: 0029681363     PISSN: 10582452     EISSN: None     Source Type: Journal    
DOI: 10.1300/j094v04n03_02     Document Type: Article

References (44)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Farn AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lcssard J, Lichtbtoun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ and Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthr Rheum 33: 160-172,1990.
2. Campbell SM, Clark S, Tindall EA, Forehand ME and Bennett RM: Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. Arthr Rheum 26:817-824, 1983.
3. Yunus M, Masi AT, Calabro JJ, Miller KA and Feigenbaum SL: Primary fibromyalgia: clinical study of 50 patients with matched normal controls. Sem Arthr Rheum 11:151-169, 1981.
4. Waylonis GW and Heck W: Fibromyalgia syndrome. New associations. Am J Phys Med Rehabil 71:343-348,1992.
5. Dinerman H, Goldenberg DL and Foison DT: A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, Sicca symptoms, ANA, low complement, and Ig deposition at the dermalepidermal junction. J Rheumat 13:368-373,1986.
6. Wolfe F: The clinical syndrome of fibrositis. Am J Med (Suppl 3) 81:7-14, 1986.
7. Muller W: The fibrositis syndrome: diagnosis, differential diagnosis and pathogenesis. Scand J Rheumatol Suppl 65:40-53, 1987.
8. Granges G and Littlcjohn GO: A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy and exercising subjects. J Rheumat 20: 344-351, 1993.
9. Dengtsson A and Henriksson KG: The muscle in fibromyalgia. A review of Swedish studies. J Rheumatol (Suppl 19) 16:144-149,1989.
10. Bengtsson A, Hcnriksson KG and Larsson J: Reduced high energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthr Rheum 29:817-821,1986.
11. Bartels EM and Danneskiold-Samsoe B: Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet i 755-757,1986.
12. Klemp P, Nielsen HV, Korsgard J and Crone P: Blood flow in fibromyotic muscles. Scand J Rehab Med 14:81-82, 1982.
13. Bengtsson A, Hcnriksson KG and Jorfeldt L et al.: Primary fibromyalgia: a clinical and laboratory study of 55 patients. Linkoping Univ Med Dissert 224: 1-21, 1986.
14. Dureltc MR, Rodriquez AA, Agrc JC and Silverman JL: Needle electromyographic evaluation of patients with myofascial or fibromyalgic pain. Am J Phys Med Rehabil 70:154-156,1991.
15. Mensc S: Considerations concerning the neurobiological basis of muscle pain. Can J Physiol Pharmacol 69:610-616, 1991.
16. Dubner R: I introductory remarks: basic mechanisms of pain associated with deep tissues. Can J Physiol Pharmacol 69:607-609, 1991.
17. Roberts WJ: A hypothesis on the physiological basis for causalgia and related pains. Pain 24:297-311, 1986.
18. Tunks F, Crook J, Norman G and Kalaher S: Tender points in fibromyalgia. Pain 34:11-19, 1988.
19. Hutchinson KJ, Johnson BW, Williams HTG and Brown GD: The histamine flare response in diabetes mellitus. Surg Gynecol Obstet 139:566-568,1974.
20. Carr RW, Delancy CA, Westcrman RA and Roberts ROD: Denervation impairs cutaneous microvascular function and blister healing in the rat hindlimb. Neurorcport 4:467-470,1993.
21. Helme RD, Littlcjohn GO and Weinstein C: Neurogenic flare responses in chronic rheumatic pain syndromes. Clin Exp Neurol 23:91-94,1987.
22. Littlejohn GO, Weinstein C and Helme RD: Increased neurogenic inflammation in fibrositis syndrome. J Rheumatol 14:1022-1025, 1987.
23. Levine JD, Dardick SJ, Basbaum AI and Scipios E: Reflex neurogenic inflammation. 1. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J Neurosci 5:1380-1386,1985.
24. Blumberg H and Wallin BG: Direct evidence of ncurally mediated vasodilatation in hairy skin of the human foot. J Physiol 382:105-121, 1987.
25. Jancso N, Jancso-Gabor A and Szolcsanyi J: Direct evidence for neurogenic inflammation and its prevention by denervation and pre-treatment with capsaicin. BrJ Pharmacol 31:138-151,1967.
26. Larkin SW and Williams TJ: Evidence for sensory nerve involvement in cutaneous reactive hyperemia in humans. Cirs Res 73:147-154, 1993.
27. Celander O and Folkow B: The nature and the distribution of afferent fibers provided with the axon reflex arrangement. Acta Physiol Scand 29:359-370, 1953.
28. 5] enkephalinamide. Eur J Pharmac 85:171-176, 1982.
29. Izumi H and Karita K: Axon reflex vasodilation in human skin measured by a laser doppler technique. Japanese J Physiology 41:693-702, 1991.
30. Izumi H and Karita K: Investigation of mechanisms of the flare and wheal reactions in human skin by band method. Brain Res 449:328-331, 1988.
31. Lembeck F and Holzer P: Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebcrgs Arch Pharmacol 310:175-183, 1979.
32. McCarson KE and Goldstein BD: Release of substance P into the superficial dorsal horn following nociceptive activation of the hindpaw of the rat. Brain Res 568:109-115, 1991.
33. Lcmbeck F and Donnerer JH: Opiod control of the function of primary afferent substance P fibres. Europ J Pharmacol 114:241-246,1985.
34. McEwan JR, Benjamin N, Larkin S, Fuller RW, Dollery CT and Maclntyre I: Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms. Circulation 77:1072-1080, 1988.
35. Stoner HB, Barker P, Riding GSG, Hazlehurst DE, Taylor L and Marcuson RW: Relationships between skin temperature and perfusion in the arm and leg. Clin Physiol 11:27-40, 1991.
36. Normell LA and Wallin BG: Sympathetic skin nerve activity and skin temperature changes in man. Acta Physiol Scand 91:417-426, 1974.
37. Uematsu S, Baden E, Breisford K, Rieselt M, Trattner M, Wolfe F and Wursta J: Reproducibility of skin temperature symmetry during a one-year period. In M Abernathy & S Uematsu (eds.) Medical Thermology. American Academy of Thermology, Washington D.C., U.S.A., pp. 99-114,1986.
38. Andersen PH, Broichmann PW and Maibach H: A corticosteroid, a nonstcroidal anti-inflammatory drug and an antihistamine modulate in vivo vascular reactions before and during post-occlusive hyperaemia. Br J Dermatol 128: 137-142, 1993.
39. Haskell WL, Sims C, Myll J, Bortz WM, St. Goar FG and Alderman EL: Coronary artery size and dilating capacity in ultradistance runners. Circulation 87:1076-1082, 1993.
40. Bennett RM: Muscle physiology and cold reactivity in the fibromyalgia syndrome. Rheum Dis Clin North Am 15:135-147, 1989.
41. Hornyak ME, Naver HK, Rydcnhag B and Wallin BG: Sympathetic activity influences the vascular axon reflex in the skin. Acta Physiol Scand 139:77-84, 1990.
42. Kregel KC, Seals DR and Callister R: Sympathetic nervous system activity during skin cooling in humans: relationship to stimulus intensity and pain sensation. J Physiol (London) 454:359-371, 1992.
43. Smythe HA: Fibrositis as a disorder of pain modulation. Clin Rheum Dis 5:823-832, 1979.
44. Helme RD: Measurement of flare responses in patients with pain. Clin Exp Neurol 24:201-206,1987.